Statistics for Insmed (id:7529 INSM)

Valuation metrics

Market cap

13.00B

Enterprise value

12.88B

Trailing P/E (ttm)

-13.70

Forward P/E

-17.18

PEG ratio

-17.18

Price/Sales (ttm)

37.91

Price/Book (mrq)

26.88

Enterprise Value/Revenue

37.56

Enterprise Value/EBITDA

-18.53

Overview

Shares outstanding

178.90M

Float

167.65M

Shares short

13.85M

% Held by insiders

0.01%

% Held by institutions

1.11%

Average volume (10 days)

1.79M

Average volume (90 days)

Price summary

52-Week low

21.92

52-Week high

80.53

52-Week change

67.27%

Beta

1.12

50-Day moving average

72.07

200-Day moving average

53.84

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

March 03th, 2011

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-252.01%

Operating margin

-212.73%

Operational effectiveness

Return on assets

-26.05%

Return on equity

-890.75%

Income statement

Revenue (ttm)

2.21

Revenue per share (ttm)

2.21

Quarterly revenue growth (yoy)

Gross profit (ttm)

239.64M

EBITDA

-695,056,000.00

Net income to common (ttm)

-864,284,992.00

Diluted EPS (ttm)

-5.55

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

1.47B

Total cash per share (mrq)

8.20

Total debt (mrq)

1.16B

Total Debt/Equity (mrq)

239.94

Current ratio (mrq)

636.50%

Book value per share (mrq)

2.70

Cash flow

Cash flow statement

-618,721,984.00

Levered free cash flow (LFCF)

-378,847,872.00